All Stories

  1. Dapsone is not a Pharmacodynamic Lead Compound for its Aryl Derivatives
  2. Exploring electrostatic patterns of human, murine, equine and canine TLR4/MD-2 receptors
  3. Mefloquine inhibits voltage dependent Nav1.4 channel by overlapping the local anaesthetic binding site
  4. Characterization of specific allosteric effects of the Na+ channel β1 subunit on the Nav1.4 isoform
  5. Why Antidiabetic Vanadium Complexes are Not in the Pipeline of “Big Pharma” Drug Research? A Critical Review
  6. Antiprotozoal Nitazoxanide Derivatives: Synthesis, Bioassays and QSAR Study Combined with Docking for Mechanistic Insight
  7. 11-Keto-β-Boswellic Acids Prevent Development of Autoimmune Reactions, Insulitis and Reduce Hyperglycemia During Induction of Multiple Low-Dose Streptozotocin (MLD-STZ) Diabetes in Mice
  8. How to Valorize Biodiversity? Letʼs Go Hashing, Extracting, Filtering, Mining, Fishing
  9. Predicting a double mutant in the twilight zone of low homology modeling for the skeletal muscle voltage-gated sodium channel subunit beta-1 (Na v 1.4 β1)
  10. Theoretical study of the structure, IR and NMR of the bis-peroxo-oxovanadate species containing-histidine peptides
  11. Interference of Boswellic Acids with the Ligand Binding Domain of the Glucocorticoid Receptor
  12. Identification of Navβ1 Residues Involved in the Modulation of the Sodium Channel Nav1.4
  13. THREE-DIMENSIONAL MAPPING OF DIFFERENTIAL AMINO ACIDS OF HUMAN, MURINE, CANINE AND EQUINE TLR4/MD-2 RECEPTOR COMPLEXES CONFERRING ENDOTOXIC ACTIVATION BY LIPID A, ANTAGONISM BY ERITORAN AND SPECIES-DEPENDENT ACTIVITIES OF LIPID IVA IN THE MAMMALIAN LPS...
  14. REVIEWING AND IDENTIFYING AMINO ACIDS OF HUMAN, MURINE, CANINE AND EQUINE TLR4 / MD-2 RECEPTOR COMPLEXES CONFERRING ENDOTOXIC INNATE IMMUNITY ACTIVATION BY LPS/LIPID A, OR ANTAGONISTIC EFFECTS BY ERITORAN, IN CONTRAST TO SPECIES-DEPENDENT MODULATION BY...
  15. Modulating testosterone pathway: a new strategy to tackle male skin aging?
  16. A proline mimetic for enantioselective aldol reaction: a quantum chemical study of a catalytic reaction with a sterically hindered l‐prolinamide derivative
  17. Recognizing Pitfalls in Virtual Screening: A Critical Review
  18. An In-Silico Approach to Primaquine Binding to Trp756 in the External Vestibule of Sodium Channel Nav 1.4
  19. Analgesic effect of leaf extract from Ageratina glabrata in the hot plate test
  20. A residue W756 in the P-loop segment of the sodium channel is critical for primaquine binding
  21. An in silico approach to primaquine binding to Trp756 in the external vestibule of sodium channel Nav 1.4
  22. Pharmacophore Design of p38α MAP Kinase Inhibitors with Either 2,4,5-Trisubstituted or 1,2,4,5-Tetrasubstituted Imidazole Scaffold
  23. Elucidation of the fragmentation pathways of different phosphatidylinositol phosphate species (PIPx) using IRMPD implemented on a FT-ICR MS
  24. Integrating computational and mixture-based screening of combinatorial libraries
  25. Reverse Pharmacognosy: Another Way to Harness the Generosity of Nature
  26. A Residue (W756) in the P-Loop Segment of Sodium Channel is Critical for Primaquine Binding
  27. Scaffold Diversity Analysis of Compound Data Sets Using an Entropy-Based Measure
  28. How to Recognize and Workaround Pitfalls in QSAR Studies: A Critical Review
  29. ChemInform Abstract: Elucidating Isoniazid Resistance Using Molecular Modeling.
  30. Structure-function analysis of two variants of mumps virus hemagglutinin-neuraminidase protein
  31. Structure-activity Relationship of Primaquine and Sodium Channel rNav 1.4
  32. Elucidating Isoniazid Resistance Using Molecular Modeling
  33. Application of Drug Repositioning Strategy to TOFISOPAM
  34. Antidiabetic Bis-Maltolato-OxoVanadium(IV): Conversion of inactive trans- to bioactive cis-BMOV for possible binding to target PTP-1B
  35. Large Compound Databases for Structure-Activity Relationships Studies in Drug Discovery
  36. Synthesis, Biological Testing, and Binding Mode Prediction of 6,9-Diarylpurin-8-ones as p38 MAP Kinase Inhibitors
  37. In silico analysis identifies a C3HC4-RING finger domain of a putative E3 ubiquitin-protein ligase located at the C-terminus of a polyglutamine-containing protein
  38. In silico analysis identifies a C3HC4-RING finger domain of a putative E3 ubiquitin-protein ligase located at the C-terminus of a polyglutamine-containing protein
  39. Isoniazid is Not a Lead Compound for its Pyridyl Ring Derivatives,Isonicotinoyl Amides, Hydrazides, and Hydrazones: A Critical Review
  40. In Silico Analysis Identifies a Novel C3HC4 Ring Finger Domain of an E3 Ubiquitin-Protein Ligase Located at the C-Terminus of a Polyglutamine-Containing Protein (AJ277365, AF525300, AY879229)
  41. Are Vanadium Compounds Drugable? Structures and Effects of Antidiabetic Vanadium Compounds: A Critical Review
  42. Synthesis and Biological Testing of Purine Derivatives as Potential ATP-Competitive Kinase Inhibitors
  43. On Rüdenberg’s Integral Approximations and Their Unrestricted and Combined Use in Crystal Orbital Theories of Hartree-Fock Type
  44. On the Restricted and Combined Use of Rüdenberg’s Approximations in Molecular Orbital Theories of Hartree-Fock Type
  45. Antitubercular Isoniazid and Drug Resistance of Mycobacterium tuberculosis — A Review
  46. Preliminary screening of some tropical plants for anti-tyrosinase activity
  47. Ethnopharmacology and bioinformatic combination for leads discovery: application to phospholipase A2 inhibitors
  48. Homology Modelling of a Newly Discovered Thioredoxin Protein and Analysis of the Force Field and Electrostatic Properties
  49. Molecular Modeling Study on Dapsone and Sulfonamides Comparing Structures and Properties with Respect to Anti-Leprosy Activity
  50. Adenosine receptors and their modulators